Neuroinformatics

, Volume 2, Issue 4, pp 399–415 | Cite as

Artificial neural networks and artificial organisms can predict alzheimer pathology in individual patients only on the basis of cognitive and functional status

  • Massimo Buscema
  • Enzo Grossi
  • David Snowdon
  • Piero Antuono
  • Marco Intraligi
  • Guido Maurelli
  • Rita Savarè
Original Article

Abstract

Data from several studies have pointed out the existence of a strong correlation between Alzheimer’s disease (AD) neuropathology and cognitive state. However, because of their highly complex and nonlinear relationship, it has been difficult to develop a predictive model for individual patient classification through traditional statistical approaches. When exposed to complex data sets, artificial neural networks (ANNs) can recognize patterns, learn the relationship of different variables, and address classification tasks. To predict the results of postmortem brain examinations, we applied ANNs to the Nun Study data set, a longitudinal epidemiological study, which includes annual cognitive and functional evaluation. One hundred seventeen subjects from the study participated in this analysis. We determined how demographic data and the cognitive and functional variables of each subject during the last year of her life could predict the presence of brain pathology expressed as Braak stages, neurofibrillary tangles (NFTs) and neuritic plaques (NPs) count in the neocortex and hippocampus, and brain atrophy. The result of this analysis was then compared with traditional statistical models. ANNs proved to be better predictors than Linear Discriminant Analysis in all experimentations (+ ∼10% in overall accuracy), especially when assembled in Artificial Organisms (+ ∼20% in overall accuracy). Demographic, cognitive, and clinical variables were better predictors of tangles count in the neocortex and in the hippocampus when compared to NPs count. These findings strengthen the hypothesis that neurofibrillary pathology may represent the major anatomic substrate of the cognitive impairment found in AD.

Index Entries

Neurofibrillary tangles (NFTs) neuritic plaques (NPs) Alzheimer’s disease (AD) artificial neural networks (ANNs) cognitive ability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arriagada, P., Growdon, J., Hedley-Whyte E., and Hyman, B. (1992a) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42, 631–639.Google Scholar
  2. Arriagada, P., Marzloff, K., and Hyman, B. (1992b) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology 42, 1681–1688.Google Scholar
  3. Braak, H. and Braak, E. (1991) Neuropathological staging of Alzheimer related changes. Acta Neuropathol. 82:239–259.CrossRefGoogle Scholar
  4. Bridle, J. S. (1989) Probabilistic Interpretation of Feedforward Classification Network Outputs, with Relationships to Statistical Pattern Recognition. In: Neuro-Computing: Algorithms, Architectures. Fogelman-Soulié, F. and Hérault, J. (eds.) Springer-Verlag, New York.Google Scholar
  5. Buscema M. (1998a) Artificial neural networks. (Special Issue Vol. I, Theory) Subst. Use Misuse Vol. 33, No. 1.Google Scholar
  6. Buscema M. (1998b) Artificial neural networks. (Special Issue Vol. II, Models) Subst. Use Misuse Vol. 33, No. 1.Google Scholar
  7. Buscema, M. (1999) Reti neurali artificiali e sistemi sociali complessi, Vol. 1, Teoria e modelli, Franco Angeli (eds.) Milano.Google Scholar
  8. Buscema, M. (1999–2003) Supervised ver. 6.45, Semeion Software, no. 12 Rome.Google Scholar
  9. Buscema, M. and Sacco PL. (2000) Feedforward networks in financial predictions: the future that modifies the present, Expet. Syst. Vol. 17, no. 3, 149–170CrossRefGoogle Scholar
  10. Buscema, M., Breda, M., and Terzi, S. (2000) Sine Net, Rome, Semeion Technical Paper, no. 21.Google Scholar
  11. Buscema, M. (2001a) T&T: a new pre-processing tool for non linear dataset. Rome, Semeion Technical Paper, no. 25.Google Scholar
  12. Buscema, M. (2001b) I.S. (Input Selection) ver. 1.0, Semeion Software, no. 17 Rome.Google Scholar
  13. Buscema, M. (2001–2002) T&T (Training & Testing) ver. 1.0, Semeion Software, no. 16 Rome.Google Scholar
  14. Buscema, M. (2002) A brief overview and introduction to artificial neural networks, Subst. Use Misuse (Special Issue on the Middle Eastern Summer Institute on Drug Use, Proceedings: 1997–1999) 37 (8–10), 1093–1148.Google Scholar
  15. Buscema, M. (2004) Genetic doping algorithm (GenD). theory and application, Expet Syst. Vol. 21, n. 2, 63–79.CrossRefGoogle Scholar
  16. Dietterich, T. (1998) Approximate statistical test for comparing supervised classification learning algorithms, Neural Comput. Vol. 10, 1895–1923.CrossRefGoogle Scholar
  17. Giannakopoulos, P., Herrmann, F. R., Bussiere, T, et al. (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease, Neurol. 60: 1495–1500.Google Scholar
  18. Giannakopoulos, P., Hof, P., Giannakopoulos, A. S., Herrmann, F., Michel, J. P., and Bouras, C. (1995) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients, Arch. Neurol. 52: 1150–1160.Google Scholar
  19. Guillozet, A. L., Weintraub, S., Mash, D. C., and Mesulam, M. M. (2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch. Neurol. 60: 729–736.CrossRefGoogle Scholar
  20. Mecocci, P., Grossi, E., Buscema, M., et al. (2002) Use of artificial networks in clinic trias: a pilot study to predict responsiveness to Donepezil in Alzheimer’s disease, J. Am. Geriatr. Soc. Vol. 50 no. 11, 1857–1860.CrossRefGoogle Scholar
  21. Morris, J. C., Heyman, A., Mohs, R. C., et al. (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical ana neuropsychological assessment of Alzheimer’s disease, Neurology 39: 1159–1165.Google Scholar
  22. Petersen, R. C. (2000) Mild cognitive impairment: transition between aging and Alzheimer’s disease, Neurologia, 15(3):93–101.Google Scholar
  23. Price, J., Davis, P., Morris, J., and White, D. (1991) The distribution of tangles, plaques, and related immunohistochemical markers in healthy aging and Alzheimer’s disease, Neurobiol. Aging 12:295–312.CrossRefGoogle Scholar
  24. Price, J. and Morris, J. (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease, Ann. Neurol. 45: 358–368.CrossRefGoogle Scholar
  25. Riley, K. P., Snowdon, D. A., and Markesbery, W. R. (2002) Alzheimer’s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study, Ann. Neurol. 51: 567–577.CrossRefGoogle Scholar
  26. Snowdon, D. A., Kemper, S. J., Morrimer, J. A., et al. (1996) Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life: findings from the Nun Study, JAMA 275: 528–532.CrossRefGoogle Scholar
  27. Vomveg, T. W., Buscema, M, Kauczor, H. U., et al. (2003) Improved artificial neural networks prediction of malignancy of lesions in contrast-enhanced MR-mammography, Med. Phys. Vol. 30 no. 9, 2350–2359.CrossRefGoogle Scholar

Suggested Readings

  1. Buscema, M. (1995) Self-reflexive networks. theory, topology, applications. Qual. Quant. Int. J. Melhodol. 29(4), 339–403.CrossRefGoogle Scholar
  2. Davis, D., Schmitt, F., Wekstein, D., and Markesbery, W. (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects, J. Neuropathol. Exp. Neurol. 58: 376–388.Google Scholar
  3. Petersen, R. C., Parisi, J. E., Johonson, K. A., et al. (1997) Neuropathological findings in patients with mild cognitive impairment, Neurology 48: A102.Google Scholar
  4. Rumelhart, D. E. and McClelland, J. L. (1986) Parallel Distributed Processing, The MIT Press, Cambridge, MA.Google Scholar

Copyright information

© The Humana Press Inc 2004

Authors and Affiliations

  • Massimo Buscema
    • 1
  • Enzo Grossi
    • 2
  • David Snowdon
    • 3
  • Piero Antuono
    • 4
  • Marco Intraligi
    • 1
  • Guido Maurelli
    • 1
  • Rita Savarè
    • 2
  1. 1.Semeion Research CenterRomeItaly
  2. 2.Bracco Medical Affairs EuropeMilanItaly
  3. 3.Sanders-Brown Center on Aging, Department of Preventive Medicine, College of MedicineUniversity of KentuckyLexington
  4. 4.The Medical College of WisconsinMilwaukee

Personalised recommendations